Home › Scleroderma › Illinois › Chicago
Pag-aaral pangklinika para sa Scleroderma sa Chicago, IL
Isang pag-aaral para sa Scleroderma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Chicago. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
Nagre-recruitPhase 2
- University of Illinois Health Outpatient Care Center, Chicago
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Nagre-recruitPhase 3
- Northwestern University, Chicago
- The University of Chicago Medical Center, Chicago
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Nagre-recruitPhase 1
- The University of Chicago Medical Center, Chicago
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Nagre-recruitPhase 2/3
- GSK Investigational Site, Chicago
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Nagre-recruitPhase 1
- Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago
Platform Clinical Study for Conquering Scleroderma
Nagre-recruitPhase 2
- The University of Chicago Medical Center (UCMC), Chicago
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Nagre-recruitPhase 2/3
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Nagre-recruitPhase 1/2
- Nkarta Investigational Site, Chicago
A Study of AZD0120 in Autoimmune Diseases
Nagre-recruitPhase 1
- Research Site, Chicago
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Nagre-recruitPhase 2
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
Pag-aaral para sa Scleroderma sa ibang lungsod
- New York City, NY11 pag-aaral
- Ann Arbor, MI10 pag-aaral
- Houston, TX9 pag-aaral
- Boston, MA7 pag-aaral
- Durham, NC7 pag-aaral
- Los Angeles, CA7 pag-aaral
- Philadelphia, PA6 pag-aaral
- Baltimore, MD6 pag-aaral
- New Orleans, LA6 pag-aaral
- Pittsburgh, PA5 pag-aaral
- Dallas, TX5 pag-aaral
- Kansas City, KS4 pag-aaral
Iba pang pag-aaral sa Chicago
- Non-Small Cell Lung Cancer62 pag-aaral
- Kanser sa Suso58 pag-aaral
- Kanser (lahat ng uri)53 pag-aaral
- Metastatic Cancer45 pag-aaral
- Kanser sa Prostate45 pag-aaral
- Obesity42 pag-aaral
- Kanser sa Baga41 pag-aaral
- Kanser sa Ovary36 pag-aaral
- Stroke35 pag-aaral
- Pagkabigo ng Puso32 pag-aaral
- Colorectal Cancer32 pag-aaral
- Overweight28 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.